Endoscopy 2004; 36(5): 471
DOI: 10.1055/s-2004-814418
Images in Focus
© Georg Thieme Verlag Stuttgart · New York

Diffuse Colonic Polyposis Detected at Screening Colonoscopy: Mantle-Cell Lymphoma

H. C. Wolfsen1 , S. R. Achem1
  • 1Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, Florida, USA
Further Information

H. C. Wolfsen, M. D.

Division of Gastroenterology and Hepatology
Mayo Clinic

4500 San Pablo Road
Jacksonville, FL 32224
USA

Fax: + 1-904-953-7260

Email: pdt@mayo.edu

Publication History

Publication Date:
21 April 2004 (online)

Table of Contents
    Zoom Image

    Figure 1 A 63-year-old asymptomatic white man was referred for screening colonoscopy, which detected diffuse polyposis throughout the colon and terminal ileum. Subsequently, similar lesions in the duodenum were found on upper endoscopy. Diffuse abdominal lymphadenopathy and thickened mucosa in the terminal ileum were identified on computed tomography.

    Zoom Image

    Figure 2 Immunohistopathological studies confirmed mantle-cell lymphoma, with a predominance of B cells confirmed with positive CD20, CD5 and cyclin D1 immunostains. Treatment with combination chemotherapy, including rituximab, was initiated.

    H. C. Wolfsen, M. D.

    Division of Gastroenterology and Hepatology
    Mayo Clinic

    4500 San Pablo Road
    Jacksonville, FL 32224
    USA

    Fax: + 1-904-953-7260

    Email: pdt@mayo.edu

    H. C. Wolfsen, M. D.

    Division of Gastroenterology and Hepatology
    Mayo Clinic

    4500 San Pablo Road
    Jacksonville, FL 32224
    USA

    Fax: + 1-904-953-7260

    Email: pdt@mayo.edu

    Zoom Image

    Figure 1 A 63-year-old asymptomatic white man was referred for screening colonoscopy, which detected diffuse polyposis throughout the colon and terminal ileum. Subsequently, similar lesions in the duodenum were found on upper endoscopy. Diffuse abdominal lymphadenopathy and thickened mucosa in the terminal ileum were identified on computed tomography.

    Zoom Image

    Figure 2 Immunohistopathological studies confirmed mantle-cell lymphoma, with a predominance of B cells confirmed with positive CD20, CD5 and cyclin D1 immunostains. Treatment with combination chemotherapy, including rituximab, was initiated.